September 21, 2023. InnoTech Precision Medicine invited to present at the RADx-Rad virtual conference.
September 20, 2023. InnoTech Precision Medicine invited to present at the Life Sciences Intelligence- Emerging MedTech Summit in Barcelona
September 12, 2023. InnoTech Precision Medicine received an NIH SBIR award for further development of their first-in-class diagnostic platform.
July 25, 2023. InnoTech Precision Medicine invited to present at the DxPx- ADLM conference in LA, USA.
June 4, 2023. InnoTech Precision Medicine Presents at the “7th Boston Paris Biotechnology Summit™”
April 19, 2023. InnoTech, a past recipient of a MassNextGen award, attends the Healey-Driscole award ceremony.
December 27, 2022. The collaboration between InnoTech Precision Medicine and Massachusetts Institute of Technology leads to the discovery of Carbon Nanotube based sensors that detect SARS-CoV-2 RNA
December 1, 2022. InnoTech Precision Medicine receives a RADx-Rad Supplement Award.
December 1, 2022. InnoTech Precision Medicine received RADx-Rad in-kind support for Business Development, Regulatory (Radcliffe Consulting), quality (Greenlight Guru and Rooks QS), Commercialization and Clinical validation.
November 15, 2022. InnoTech Precision Medicine is one of the finalists for DxPx-Medica 2022 pitch competition in Dusseldorf Germany.
September 17, 2022. InnoTech Precision Medicine is the first place winner of EPPICON 2022 pitch competition at Santa Clara California.
September 12, 2022. Our IP attorneys Dr. Ashley Brzezinski and Mr. Chuck Larsen have moved to McDermott& Emery LLP and InnoTech Precision Medicines IP portfolio is transferred with them.
September 8, 2022. InnoTech Precision Medicine and Wainamics Inc (Pleasanton, California) sign an agreement for development of InnoTech’s disease-specific microfluidic cartridge.
September 1, 2022. InnoTech Precision Medicine is the recipient of a RADx-RAD supplement award through NIH to continue development of their next generation diagnostic platform
May 11, 2022. InnoTech Precision Medicine wins the first prize for the M2D2-BARDA-Impact accelerator pitch competition.
Jan. 2, 2022, InnoTech Precision Medicine is selected as one of the M2D2-BARDA-Impact accelerator participants
November 10. 2021. The collaborative studies between InnoTech Precision Medicine and Massachusetts Institute of Technology leads to the discovery of New Carbon Nanotube-Based Sensor Can Detect SARS-CoV-2 Proteins
November 9, 2021: The results of the collaboration between InnoTech Precision Medicine and Massachusetts Institute of Technology is Published. ”Antibody-Free Rapid Detection of SARS-CoV-2 Proteins Using Corona Phase Molecular Recognition to Accelerate Development Time”.
June 14, 2021 Baker-Polito Administration Announces Awards for Massachusetts Life Sciences Center Initiative for Women Entrepreneurs. InnoTech’s CEO, Dr. Roya Khosravi-Far is one of the awardees
May 24, 2021: MassMEDIC Announces IGNITE 2021 Cohort
April 19, 2021. InnoTech Precision Medicine engages White & Case LLP for our intellectual property activities.
March 22, 2021: InnoTech awarded RADx-rad funding to develop new rapid, low cost COVID-19 detection technology.
March 22, 2021: Dr. Carlos Aparacio joins InnoTech Precision Medicine as our Chief Operation Officer. He brings over 30 years of medical device and diagnostics product development and commercialization to our company.
March 1, 2021: InnoTech Precision Medicine and Massachusetts Institute of Technology sign a cooperative agreement including a licensing agreement.
March 1, 2021: Mr. Joe St.Germain joins our company as Outside Chief Financial Officer.
January 18, 2021: Company Launch Partners has selected InnoTech as one of their Early-Stage Launch Program companies.
January 5, 2021: InnoTech is selected as one of the National Institute of Health recipients of the Rapid Acceleration of Diagnostics (RADx) award
December 21, 2020: InnoTech receives RADx-rad funding from the National Institute of Health for the development of a multimodal platform for detection of COVID-19
July 1, 2020: InnoTech Precision Medicine retains Triunity Law Group for our corporate legal council.